Commit To Buy Celldex Therapeutics At $3, Earn 30% Using Options

Investors eyeing a purchase of Celldex Therapeutics, Inc. (CLDX) shares, but tentative about paying the going market price of $4.21/share, might benefit from considering selling puts among the alternative strategies at their disposal..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.